Effect of Empagliflozin on Ventricular Repolarization.

Summary

The present project aims to investigate if the empagliflozin has an antiarrhythmic action. Analyzing the T-wave heterogeneity index, a new electrocardiographic risk marker associated with the prediction of cardiovascular risk, in diabetic patients and coronary artery disease, the investigators will verify if empagliflozin is associated with a reduction in electrical instability.

Timeline

Start

2019-10-04

Primary completion

2024-03-31

Completion

2024-03-31

Drugs

Indications